Form 8-K - Current report:
SEC Accession No. 0001193125-26-008307
Filing Date
2026-01-09
Accepted
2026-01-09 08:07:15
Documents
50
Period of Report
2026-01-09
Items
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d15047d8k.htm   iXBRL 8-K 33080
2 EX-99.1 d15047dex991.htm EX-99.1 56142
6 GRAPHIC g15047ex99_1s10g1.jpg GRAPHIC 63128
7 GRAPHIC g15047ex99_1s11g1.jpg GRAPHIC 93376
8 GRAPHIC g15047ex99_1s12g1.jpg GRAPHIC 70538
9 GRAPHIC g15047ex99_1s13g1.jpg GRAPHIC 105284
10 GRAPHIC g15047ex99_1s14g1.jpg GRAPHIC 130571
11 GRAPHIC g15047ex99_1s15g1.jpg GRAPHIC 142545
12 GRAPHIC g15047ex99_1s16g1.jpg GRAPHIC 76938
13 GRAPHIC g15047ex99_1s17g1.jpg GRAPHIC 99385
14 GRAPHIC g15047ex99_1s18g1.jpg GRAPHIC 103637
15 GRAPHIC g15047ex99_1s19g1.jpg GRAPHIC 74069
16 GRAPHIC g15047ex99_1s1g1.jpg GRAPHIC 60236
17 GRAPHIC g15047ex99_1s20g1.jpg GRAPHIC 72867
18 GRAPHIC g15047ex99_1s21g1.jpg GRAPHIC 110315
19 GRAPHIC g15047ex99_1s22g1.jpg GRAPHIC 32197
20 GRAPHIC g15047ex99_1s23g1.jpg GRAPHIC 135722
21 GRAPHIC g15047ex99_1s24g1.jpg GRAPHIC 87970
22 GRAPHIC g15047ex99_1s25g1.jpg GRAPHIC 101855
23 GRAPHIC g15047ex99_1s26g1.jpg GRAPHIC 71185
24 GRAPHIC g15047ex99_1s27g1.jpg GRAPHIC 92875
25 GRAPHIC g15047ex99_1s28g1.jpg GRAPHIC 90292
26 GRAPHIC g15047ex99_1s29g1.jpg GRAPHIC 134991
27 GRAPHIC g15047ex99_1s2g1.jpg GRAPHIC 231407
28 GRAPHIC g15047ex99_1s30g1.jpg GRAPHIC 80108
29 GRAPHIC g15047ex99_1s31g1.jpg GRAPHIC 155579
30 GRAPHIC g15047ex99_1s32g1.jpg GRAPHIC 97650
31 GRAPHIC g15047ex99_1s33g1.jpg GRAPHIC 101932
32 GRAPHIC g15047ex99_1s34g1.jpg GRAPHIC 119636
33 GRAPHIC g15047ex99_1s35g1.jpg GRAPHIC 77089
34 GRAPHIC g15047ex99_1s36g1.jpg GRAPHIC 109365
35 GRAPHIC g15047ex99_1s37g1.jpg GRAPHIC 30355
36 GRAPHIC g15047ex99_1s3g1.jpg GRAPHIC 52602
37 GRAPHIC g15047ex99_1s4g1.jpg GRAPHIC 92416
38 GRAPHIC g15047ex99_1s5g1.jpg GRAPHIC 93254
39 GRAPHIC g15047ex99_1s6g1.jpg GRAPHIC 98980
40 GRAPHIC g15047ex99_1s7g1.jpg GRAPHIC 93788
41 GRAPHIC g15047ex99_1s8g1.jpg GRAPHIC 29485
42 GRAPHIC g15047ex99_1s9g1.jpg GRAPHIC 122435
  Complete submission text file 0001193125-26-008307.txt   5101715

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA ntla-20260109.xsd EX-101.SCH 2844
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE ntla-20260109_lab.xml EX-101.LAB 17991
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ntla-20260109_pre.xml EX-101.PRE 11256
52 EXTRACTED XBRL INSTANCE DOCUMENT d15047d8k_htm.xml XML 3630
Mailing Address 40 ERIE STREET SUITE 130 CAMBRIDGE MA 02139
Business Address 40 ERIE STREET SUITE 130 CAMBRIDGE MA 02139 857-285-6200
Intellia Therapeutics, Inc. (Filer) CIK: 0001652130 (see all company filings)

EIN.: 364785571 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37766 | Film No.: 26521383
SIC: 2835 In Vitro & In Vivo Diagnostic Substances
(CF Office: 03 Life Sciences)